Sripathi M. Sureban

3.3k total citations
51 papers, 2.5k citations indexed

About

Sripathi M. Sureban is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Sripathi M. Sureban has authored 51 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 27 papers in Oncology and 9 papers in Surgery. Recurrent topics in Sripathi M. Sureban's work include Cancer Cells and Metastasis (18 papers), MicroRNA in disease regulation (6 papers) and RNA modifications and cancer (6 papers). Sripathi M. Sureban is often cited by papers focused on Cancer Cells and Metastasis (18 papers), MicroRNA in disease regulation (6 papers) and RNA modifications and cancer (6 papers). Sripathi M. Sureban collaborates with scholars based in United States, India and Egypt. Sripathi M. Sureban's co-authors include Courtney W. Houchen, Randal May, Shrikant Anant, Dongfeng Qu, Nathaniel Weygant, Naushad Ali, Parthasarathy Chandrakesan, Rama P. Ramanujam, Stan Lightfoot and Brian K. Dieckgraefe and has published in prestigious journals such as Gastroenterology, PLoS ONE and Cancer Research.

In The Last Decade

Sripathi M. Sureban

51 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sripathi M. Sureban United States	28	1.3k	1.2k	598	370	333	51	2.5k
Yoshitaka Hippo Japan	27	2.1k 1.6×	892 0.7×	681 1.1×	421 1.1×	383 1.2×	64	3.3k
Andrea Sacchetti Netherlands	25	1.2k 0.9×	821 0.7×	401 0.7×	135 0.4×	233 0.7×	50	2.4k
Eileen Friedman United States	36	2.1k 1.6×	1.1k 0.9×	358 0.6×	308 0.8×	176 0.5×	75	3.2k
Christophe Denoyelle France	24	2.2k 1.7×	1.0k 0.8×	941 1.6×	499 1.3×	270 0.8×	50	3.6k
Maria Letizia Motti Italy	21	1.2k 0.9×	757 0.6×	308 0.5×	174 0.5×	149 0.4×	42	1.8k
Tomoki Yamatsuji Japan	29	1.2k 0.9×	531 0.4×	306 0.5×	423 1.1×	461 1.4×	117	2.3k
Gianluca Bossi Italy	30	1.4k 1.0×	988 0.8×	547 0.9×	167 0.5×	98 0.3×	53	2.2k
Peng‐Sheng Zheng China	33	1.8k 1.3×	631 0.5×	868 1.5×	395 1.1×	153 0.5×	73	2.7k
Liudmila L. Kodach Netherlands	22	1.0k 0.8×	633 0.5×	467 0.8×	144 0.4×	376 1.1×	53	1.9k
Sudha K. Pai United States	20	2.1k 1.6×	916 0.8×	945 1.6×	282 0.8×	118 0.4×	31	2.9k

Countries citing papers authored by Sripathi M. Sureban

Since Specialization

Citations

This map shows the geographic impact of Sripathi M. Sureban's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sripathi M. Sureban with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sripathi M. Sureban more than expected).

Fields of papers citing papers by Sripathi M. Sureban

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sripathi M. Sureban. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sripathi M. Sureban. The network helps show where Sripathi M. Sureban may publish in the future.

Co-authorship network of co-authors of Sripathi M. Sureban

This figure shows the co-authorship network connecting the top 25 collaborators of Sripathi M. Sureban. A scholar is included among the top collaborators of Sripathi M. Sureban based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sripathi M. Sureban. Sripathi M. Sureban is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Moore, Landon L., Dongfeng Qu, Sripathi M. Sureban, et al.. (2024). From Inflammation to Oncogenesis: Tracing Serum DCLK1 and miRNA Signatures in Chronic Liver Diseases. International Journal of Molecular Sciences. 25(12). 6481–6481. 4 indexed citations

Vignesh, Ramachandran, Vijayakumar Velu, & Sripathi M. Sureban. (2021). Could Nutraceutical Approaches Possibly Attenuate the Cytokine Storm in COVID-19 Patients?. Frontiers in Cellular and Infection Microbiology. 11. 667733–667733. 2 indexed citations

Chandrakesan, Parthasarathy, Randal May, Nathaniel Weygant, et al.. (2016). Intestinal tuft cells regulate the ATM mediated DNA Damage response via Dclk1 dependent mechanism for crypt restitution following radiation injury. Scientific Reports. 6(1). 37667–37667. 36 indexed citations

Sureban, Sripathi M., Dongfeng Qu, & Courtney W. Houchen. (2015). Regulation of miRNAs by Agents Targeting the Tumor Stem Cell Markers DCLK1, MSI1, LGR5, and BMI1. Current Pharmacology Reports. 1(4). 217–222. 12 indexed citations

Qu, Dongfeng, Nathaniel Weygant, Randal May, et al.. (2015). Ablation of Doublecortin-Like Kinase 1 in the Colonic Epithelium Exacerbates Dextran Sulfate Sodium-Induced Colitis. PLoS ONE. 10(8). e0134212–e0134212. 56 indexed citations

Sureban, Sripathi M., Randal May, Nathaniel Weygant, et al.. (2014). XMD8-92 inhibits pancreatic tumor xenograft growth via a DCLK1-dependent mechanism. Cancer Letters. 351(1). 151–161. 103 indexed citations

Ganapathy, Vengatesh, Elizabeth M. Gillies, Isabel Fonseca, et al.. (2014). Wnt inhibitory factor 1 suppresses cancer stemness and induces cellular senescence. Cell Death and Disease. 5(5). e1246–e1246. 57 indexed citations

Weygant, Nathaniel, Dongfeng Qu, William L. Berry, et al.. (2014). Small molecule kinase inhibitor LRRK2-IN-1 demonstrates potent activity against colorectal and pancreatic cancer through inhibition of doublecortin-like kinase 1. Molecular Cancer. 13(1). 103–103. 92 indexed citations

Ali, Naushad, Ted Bader, Randal May, et al.. (2013). Correction: Fluvastatin Interferes with Hepatitis C Virus Replication via Microtubule Bundling and a Doublecortin-like Kinase-Mediated Mechanism. PLoS ONE. 8(12). 8 indexed citations

10.

Ali, Naushad, Ted Bader, Randal May, et al.. (2013). Fluvastatin Interferes with Hepatitis C Virus Replication via Microtubule Bundling and a Doublecortin-like Kinase-Mediated Mechanism. PLoS ONE. 8(11). e80304–e80304. 26 indexed citations

11.

Sureban, Sripathi M., Randal May, Stan Lightfoot, et al.. (2011). DCAMKL-1 Regulates Epithelial–Mesenchymal Transition in Human Pancreatic Cells through a miR-200a –Dependent Mechanism. Cancer Research. 71(6). 2328–2338. 169 indexed citations

12.

Vega, Kenneth J., Randal May, Sripathi M. Sureban, et al.. (2011). Identification of the putative intestinal stem cell marker doublecortin and CaM kinase‐like‐1 in Barrett's esophagus and esophageal adenocarcinoma. Journal of Gastroenterology and Hepatology. 27(4). 773–780. 59 indexed citations

13.

May, Randal, Sripathi M. Sureban, Stan Lightfoot, et al.. (2010). Identification of a novel putative pancreatic stem/progenitor cell marker DCAMKL-1 in normal mouse pancreas. American Journal of Physiology-Gastrointestinal and Liver Physiology. 299(2). G303–G310. 57 indexed citations

14.

Govindarajan, Kathiravan & Sripathi M. Sureban. (2009). Effect of taxol from Pestalotiopsis mangiferae on A549 cells-In vitro study.. PubMed Central. 8 indexed citations

15.

Sureban, Sripathi M., Randal May, Satish Ramalingam, et al.. (2009). Selective Blockade of DCAMKL-1 Results in Tumor Growth Arrest by a Let-7a MicroRNA-Dependent Mechanism. Gastroenterology. 137(2). 649–659.e2. 104 indexed citations

16.

Bishnupuri, Kumar S., Qizhi Luo, Sripathi M. Sureban, et al.. (2009). Reg IV Regulates Normal Intestinal and Colorectal Cancer Cell Susceptibility to Radiation-Induced Apoptosis. Gastroenterology. 138(2). 616–626.e2. 49 indexed citations

17.

Subramaniam, Dharmalingam, Randal May, Sripathi M. Sureban, et al.. (2008). Diphenyl Difluoroketone: A Curcumin Derivative with Potent In vivo Anticancer Activity. Cancer Research. 68(6). 1962–1969. 137 indexed citations

18.

Sureban, Sripathi M., Satish Ramalingam, Gopalan Natarajan, et al.. (2008). Translation regulatory factor RBM3 is a proto-oncogene that prevents mitotic catastrophe. Oncogene. 27(33). 4544–4556. 110 indexed citations

19.

George, Robert, Mark Sturmoski, Randal May, et al.. (2008). Loss of p21^{Waf1/Cip1/Sdi1}enhances intestinal stem cell survival following radiation injury. American Journal of Physiology-Gastrointestinal and Liver Physiology. 296(2). G245–G254. 20 indexed citations

20.

Sureban, Sripathi M., Nabendu Murmu, Pavel Rodriguez, et al.. (2006). Functional Antagonism Between RNA Binding Proteins HuR and CUGBP2 Determines the Fate of COX-2 mRNA Translation. Gastroenterology. 132(3). 1055–1065. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact